Ghost Tree Capital, LLC Tg Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

$245 Million
Q2 2024

A detailed history of Ghost Tree Capital, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 500,000 shares of TGTX stock, worth $11.9 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares

500,000

Previous 825,000 39.39%

Holding current value

$11.9 Million

Previous $12.5 Million 29.11%

% of portfolio

3.63%

Previous 4.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $4.33 Million - $6.24 Million	-325,000 Reduced 39.39%	500,000 $8.9 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $7.49 Million - $12.2 Million	575,000 Added 230.0%	825,000 $12.5 Million
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $5.01 Million - $14.1 Million	-750,000 Reduced 75.0%	250,000 $4.27 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $1.46 Million - $4.64 Million	175,000 Added 21.21%	1,000,000 $8.36 Million
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $4.26 Million - $9.63 Million	-275,000 Reduced 25.0%	825,000 $20.5 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $11.3 Million - $21.3 Million	1,100,000 New	1,100,000 $16.5 Million
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $3.92 Million - $7.28 Million	-180,000 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$32.5 - $48.96 $650,000 - $979,200	-20,000 Reduced 10.0%	180,000 $6.98 Million
Q1 2021 May 14, 2021	SELL	$41.61 - $54.3 $2.08 Million - $2.72 Million	-50,000 Reduced 20.0%	200,000 $9.64 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $1.26 Million - $2.75 Million	50,000 Added 25.0%	250,000 $13 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $7.4 Million - $10.9 Million	-400,000 Reduced 66.67%	200,000 $5.35 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $3.56 Million - $8.74 Million	400,000 Added 200.0%	600,000 $11.7 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $978,180 - $2.19 Million	137,000 Added 217.46%	200,000 $1.97 Million
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $321,300 - $705,600	63,000 New	63,000 $699,000
Q4 2018 Feb 14, 2019	SELL	$3.44 - $5.76 $156,520 - $262,080	-45,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $33,475 - $91,000	-6,500 Reduced 12.5%	45,500 $255,000
Q2 2018 Aug 14, 2018	SELL	$12.5 - $15.0 $3.1 Million - $3.72 Million	-248,000 Reduced 82.67%	52,000 $684,000
Q1 2018 May 15, 2018	BUY	$8.7 - $16.8 $2.61 Million - $5.04 Million	300,000 New	300,000 $4.26 Million

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Tg Therapeutics, Inc. Transaction History